These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33311977)

  • 1. The Relationship Between the "Adherence Starts with Knowledge-20" Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study.
    Akimoto K; Hirai K; Matsunaga T; Kaneko K; Mikuni H; Kawahara T; Uno T; Fujiwara A; Miyata Y; Ohta S; Homma T; Inoue H; Yamaguchi F; Kusumoto S; Suzuki S; Tanaka A; Sagara H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3201-3211. PubMed ID: 33311977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.
    Kokturk N; Polatli M; Oguzulgen IK; Saleemi S; Al Ghobain M; Khan J; Doble A; Tariq L; Aziz F; El Hasnaoui A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1377-1388. PubMed ID: 29731625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
    Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist involvement in the inhaler choice improves lung function in patients with COPD: a prospective single-arm study.
    Shiwaku E; Dote S; Kaneko S; Hei C; Aikawa M; Sakai Y; Kawai T; Iwatsubo S; Hashimoto M; Tsuneishi T; Nishimura T; Iwata T; Hira D; Terada T; Nishimura T; Kobayashi Y
    J Pharm Health Care Sci; 2021 Aug; 7(1):28. PubMed ID: 34334137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study.
    Lou P; Zhu Y; Chen P; Zhang P; Yu J; Zhang N; Chen N; Zhang L; Wu H; Zhao J
    BMC Pulm Med; 2012 Sep; 12():53. PubMed ID: 22958576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Quality of Life in Subjects With Stable COPD.
    Ekici A; Bulcun E; Karakoc T; Senturk E; Ekici M
    Respir Care; 2015 Nov; 60(11):1585-91. PubMed ID: 26152471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.
    Toyama T; Kawayama T; Kinoshita T; Imamura Y; Yoshida M; Takahashi K; Fujii K; Higashimoto I; Hoshino T
    Intern Med; 2019 Jan; 58(2):175-185. PubMed ID: 30210101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of the Hospital Anxiety and Depression Scale for identifying depression in chronic obstructive pulmonary disease patients.
    Nowak C; Sievi NA; Clarenbach CF; Schwarz EI; Schlatzer C; Brack T; Brutsche M; Frey M; Irani S; Leuppi JD; Rüdiger J; Thurnheer R; Kohler M
    Pulm Med; 2014; 2014():973858. PubMed ID: 25548667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease.
    Chang CH; Chuang LP; Lin SW; Lee CS; Tsai YH; Wei YF; Cheng SL; Hsu JY; Kuo PH; Yu CJ; Chen NH
    BMC Pulm Med; 2016 Aug; 16(1):118. PubMed ID: 27501837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T
    Respir Med; 2000 Sep; 94(9):841-6. PubMed ID: 11001074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis.
    Zhou Z; Zhou A; Zhao Y; Duan J; Chen P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1675-1682. PubMed ID: 29872285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.
    Lopez-Campos JL; Fernandez-Villar A; Calero-Acuña C; Represas-Represas C; Lopez-Ramírez C; Fernández VL; Soler-Cataluña JJ; Casamor R;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():975-84. PubMed ID: 26064045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.
    Negewo NA; Gibson PG; Wark PA; Simpson JL; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2929-2942. PubMed ID: 29062230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study.
    Contoli M; Rogliani P; Di Marco F; Braido F; Corsico AG; Amici CA; Piro R; Sarzani R; Lessi P; Scognamillo C; Scichilone N; Santus P;
    Ther Adv Respir Dis; 2019; 13():1753466619888128. PubMed ID: 31760881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.
    Müllerová H; Landis SH; Aisanov Z; Davis KJ; Ichinose M; Mannino DM; Maskell J; Menezes AM; van der Molen T; Oh YM; Tabberer M; Han MK
    Int J Chron Obstruct Pulmon Dis; 2016; 11():881-90. PubMed ID: 27217741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.